Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2020
Rong LQ, Kaushal M, Mauer E, Pryor KO, Kenfield M, Shore-Lesseron L, Gaudino MFL, Neuburger PJ.  2020.  Two- or 3-Dimensional Echocardiography-Derived Cardiac Output Cannot Replace the Pulmonary Artery Catheter in Cardiac Surgery.. J Cardiothorac Vasc Anesth.
2019
Noori SA, Rasheed A, Aiyer R, Jung B, Bansal N, Chang K-V, Ottestad E, Gulati A.  2019.  Therapeutic Ultrasound for Pain Management in Chronic Low Back Pain and Chronic Neck Pain: A Systematic Review.. Pain Med.
Rong LQ, Neuburger PJ, De Paulis S, Kim J.  2019.  Thinking Outside the Heart: An Innovative Approach of Speckle Tracking With Transesophageal Echocardiography.. J Cardiothorac Vasc Anesth.
Rong LQ, Hameed I, Salemi A, Rahouma M, Khan FM, Wijeysundera HC, Angiolillo DJ, Shore-Lesserson L, Biondi-Zoccai G, Girardi LN et al..  2019.  Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis.. J Am Heart Assoc. 8(19):e013463.
Hemmings HC, Riegelhaupt PM, Kelz MB, Solt K, Eckenhoff RG, Orser BA, Goldstein PA.  2019.  Towards a Comprehensive Understanding of Anesthetic Mechanisms of Action: A Decade of Discovery.. Trends Pharmacol Sci. 40(7):464-481.
2018
Pryor KO, Veselis RA.  2018.  Tenth International Symposium on Memory and Awareness in Anaesthesia.. Br J Anaesth. 121(1):189-191.
2016
Gausden EBishop, Garner MR, Warner SJ, Levack A, Nellestein AM, Tedore T, Flores E, Lorich DG.  2016.  Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients.. BMJ Open. 6(6):e010676.
Voudris KV, S Wong C, Kaple R, Kampaktsis PN, de Biasi AR, Weiss JS, Devereux R, Krieger K, Kim L, Swaminathan RV et al..  2016.  Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation.. J Cardiothorac Surg. 11(1):158.
2015
Skubas NJ.  2015.  Teaching whole body point-of-care ultrasound: advancing the skills of tomorrow's anesthesiologists.. Anesthesiology. 123(3):499-500.
Picollo A, Malvezzi M, Accardi A.  2015.  TMEM16 proteins: unknown structure and confusing functions.. J Mol Biol. 427(1):94-105.
2014
Lolicato M, Riegelhaupt PM, Arrigoni C, Clark KA, Minor DL.  2014.  Transmembrane helix straightening and buckling underlies activation of mechanosensitive and thermosensitive K(2P) channels.. Neuron. 84(6):1198-212.
2012
Ying S-W, Kanda VA, Hu Z, Purtell K, King EC, Abbott GW, Goldstein PA.  2012.  Targeted deletion of Kcne2 impairs HCN channel function in mouse thalamocortical circuits.. PLoS One. 7(8):e42756.
Sniecinski RM, Skubas NJ, London MJ.  2012.  Testing cardiac reserve: then and now. 1923.. Anesth Analg. 115(5):991-2.
Heerdt PM, Kant R, Hu Z, Kanda VA, Christini DJ, Malhotra JK, Abbott GW.  2012.  Transcriptomic analysis reveals atrial KCNE1 down-regulation following lung lobectomy.. J Mol Cell Cardiol. 53(3):350-3.
2011
Fleischut PM, Evans AS, Nugent WC, Faggiani SL, Lazar EJ, Liebowitz RS, Forese LL, Kerr GE.  2011.  Ten years after the IOM report: Engaging residents in quality and patient safety by creating a House Staff Quality Council.. Am J Med Qual. 26(2):89-94.
Rusinova R, Herold KF, R Sanford L, Greathouse DV, Hemmings HC, Andersen OS.  2011.  Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.. J Gen Physiol. 138(2):249-70.
2010
Roepke TK, Purtell K, King EC, La Perle KMD, Lerner DJ, Abbott GW.  2010.  Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.. PLoS One. 5(7):e11451.
2008
Roepke TK, Kontogeorgis A, Ovanez C, Xu X, Young JB, Purtell K, Goldstein PA, Christini DJ, Peters NS, Akar FG et al..  2008.  Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).. FASEB J. 22(10):3648-60.
Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL.  2008.  Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus.. J Neurosci. 28(1):106-15.